Intraoperative use of tranexamic acid in the control of bleeding in long bone fracture surgeries: a meta-analysis


  • Manuel A. Gaspar Jr Department of Orthopaedics, Cagayan Valley Medical Center, Tuguegarao City, Cagayan, Philippines
  • Marco Paolo G. Lasam Department of Orthopaedics, Cagayan Valley Medical Center, Tuguegarao City, Cagayan, Philippines



Intraoperative use of tranexamic acid, Long bone fracture surgery, Blood loss, Control of bleeding, Meta-analysis


Tranexamic acid (TXA) has been used successfully in the practice of orthopedics to reduce perioperative blood loss, particularly in total hip and knee arthroplasty and spine surgery. The use of TXA has shown potential to reduce blood loss, transfusion rates and volumes, perioperative hemoglobin change and hospital-related costs at various degrees. This review aimed to evaluate the clinical results of the intraoperative use of TXA in long bone fracture surgeries. Relevant electronic articles were reviewed through a systematic search and selection process, resulting in the selection of five randomized control trials with a total of 295 participants. These studies compared the primary outcome of this meta-analysis, which was blood loss. Four of the studies included post-operative hemoglobin levels as their outcomes. Furthermore, two studies compared drop in hemoglobin levels, while three studies included blood transfusion events. Results showed a significant difference in terms of total blood loss when intraoperative administration of TXA was compared to placebo in long bone surgeries with a mean difference of -76.94 [-106.62, -47.26] (95% CI) (p≤0.00001). There was no significant difference in terms of post-operative hemoglobin levels (p=0.27) with a mean difference of 0.31 [-0.24, 0.86] (95% CI). No significant difference was also shown between the two groups as to drop in hemoglobin levels (p=0.29) with a mean difference of -0.34 [-0.97, 0.29] (95% CI). This meta-analysis showed that intraoperative use of TXA given during long bone fracture surgeries can effectively reduce total blood loss and reduce risk of transfusion events or avoid transfusion events.

Author Biographies

Manuel A. Gaspar Jr, Department of Orthopaedics, Cagayan Valley Medical Center, Tuguegarao City, Cagayan, Philippines

Department of Orthopaedics

Medical Officer IV

Marco Paolo G. Lasam, Department of Orthopaedics, Cagayan Valley Medical Center, Tuguegarao City, Cagayan, Philippines

Department of Orthopaedics

Medical Specialist III


Ng W, Jerath A, Wąsowicz M. Tranexamic acid: a clinical review. Anaesthesiol Intensive Ther. 2015;47(4):339-50.

Hunt BJ. The current place of tranexamic acid in the management of bleeding. Anaesthesia. 2015;70(1):50-8.

Robb PJ. Tranexamic acid-a useful drug in ENT surgery? J Laryngol Otol. 2014;128(7):574-9.

Lin ZX, Woolf SK. Safety, efficacy, and cost-effectiveness of tranexamic acid in orthopedic surgery. Orthopedics. 2016;39(2):119-30.

Bantolo A, Detoyato LYK (2019). Tranexamic acid pre-operative prophylaxis to reduce bleeding during open reduction internal fixation with interlocked intramedullary nailing of the femur: a randomized control study. Int J Scientif Res Publicat. 2019;10(10):102-9.

Haghighi M, Ettehad H, Mardani-Kivi M, Mirbolook A, Nabi BN, Moghaddam R, et al. Does tranexamic acid reduce bleeding during femoral fracture operation? Arch Bone Joint Surg. 2017;5(2):103-8.

Lei J, Zhang B, Cong Y, Zhuang Y, Wei X, Fu Y, et al. Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial. J Orthop Surg Res. 2017;12(1):124.

Mukherjee M, Biswas C, Chatterjee S, Bandyopadhyay BK. Comparative study of efficacy of reduction of blood loss by tranexamic acid and epsilon aminocaproic acid for orthopedic femoral surgeries. Anaesth Pain Intensive Care. 2016;20(4):417-21.

Luo X, He S, Lin Z, Li Z, Huang C, Li Q. Efficacy and safety of tranexamic acid for controlling bleeding during surgical treatment of intertrochanteric fragility fracture with proximal femoral nail anti-rotation: a randomized controlled trial. Indian J Orthopaed. 2019;53(2):263-9.

Delanois R, Mont M. (2013) Does tranexamic acid reduce blood loss in total knee arthroplasty? commentary on an article by X. Aguilera, MD, et al.: efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty. a randomized controlled clinical trial. J Bone Joint Surg. 2013;95(22):179.

Eva Y.W. Tse, MBChB etal.(2011) Current Concepts Review Reducing Perioperative Blood Loss and Allogeneic Blood Transfusion in Patients Undergoing Major Spine Surgery Department of Anaesthesiology and the Department of Orthopaedics and Traumatology, The University of Hong Kong, Hong Kong SAR, China THE JOURNAL OF BONE AND JOINT SURGERY, INCORPORATED

Tse EYW, Cheung WY, Ng KFJ, Luk KDK. Oral and intravenous tranexamic acid are equivalent at reducing blood loss following total hip arthroplasty a randomized controlled trial Rush university medical center, Chicago, Illinois. J Bone Joint Surg Am. 2011;93(13):1268-77.

Gill JB, Chin Y, Levin A, Feng D. The use of antifibrinolytic agents in spine surgery a meta-analysis. J Bone Joint Surg Am. 2008;90(11):2399-407.

Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE. Tranexamic acid in trauma: how should we use it? J Trauma Acute Care Surg. 2013;74(6):1575-86.

Ponnusamy KE, Kim TJ, Khanuja HS. Current concepts review perioperative blood transfusions in orthopaedic surgery. J Bone Joint Surg Am. 2014;96(21):1836-44.